| Literature DB >> 35887890 |
Shang-Yen Wu1, Jen-Hung Wang2, Cheng-Jen Chiu1,3.
Abstract
PURPOSE: This study aims to assess the satisfaction, compliance, and side effects among the long-term orthokeratology (Ortho-K) users in a tertiary hospital in Taiwan and analyze the side effects and related risk factors.Entities:
Keywords: compliance; myopia; orthokeratology (Ortho-k); satisfaction; survey
Year: 2022 PMID: 35887890 PMCID: PMC9321806 DOI: 10.3390/jcm11144126
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Demographics of orthokeratology wearers.
| Variable | Male | Female | Total | |
|---|---|---|---|---|
| Numbers | 155 | 150 | 305 | |
|
| 12.77 ± 2.87 | 13.49 ± 3.83 | 13.13 ± 3.39 | 0.066 |
|
| 24 (15.5%) | 38 (25.3%) | 62 (20.3%) | 0.033 * |
|
| ||||
| Initial Visual Acuity (logMAR) | 0.06 ± 0.04 | 0.05 ± 0.04 | 0.06 ± 0.04 | 0.235 |
| Initial Sphere | −3.22 ± 1.81 | −3.80 ± 1.88 | −3.51 ± 1.86 | 0.006 * |
| Initial Cylinder | −0.83 ± 0.65 | −1.05 ± 0.96 | −0.94 ± 0.83 | 0.022 * |
| Average Keratometry | 42.95 ± 1.20 | 43.51 ± 1.44 | 43.23 ± 1.35 | <0.001 * |
| Initial Axial Length | 25.30 ± 1.08 | 24.98 ± 1.07 | 25.14 ± 1.08 | 0.012 * |
|
| ||||
| Initial Visual Acuity (logMAR) | 0.06 ± 0.04 | 0.05 ± 0.04 | 0.06 ± 0.04 | 0.531 |
| Initial Sphere | −3.10 ± 1.84 | −3.66 ± 1.85 | −3.38 ± 1.86 | 0.009 * |
| Initial Cylinder | −0.98 ± 0.69 | −1.19 ± 0.95 | −1.08 ± 0.84 | 0.026 * |
| Average Keratometry | 43.00 ± 1.22 | 43.53 ± 1.46 | 43.26 ± 1.36 | 0.001 * |
| Initial Axial Length | 25.25 ± 1.09 | 24.95 ± 1.09 | 25.10 ± 1.09 | 0.017 * |
|
| 0.977 | |||
| High school and lower | 29 (19.3%) | 29 (19.5%) | 58 (19.4%) | |
| College and higher | 121 (80.7%) | 120 (80.5%) | 241 (80.6%) | |
|
| 0.721 | |||
| High school and lower | 29 (18.8%) | 25 (17.2%) | 54 (18.1%) | |
| College and higher | 125 (81.2%) | 120 (82.8%) | 245 (81.9%) | |
|
| 0.437 | |||
| Low myopia (>−3D) | 72 (48.3%) | 61 (41.2%) | 134 (44.8%) | |
| Moderate myopia (between −6D and −3D) | 46 (30.5%) | 49 (33.1%) | 95 (31.8%) | |
| High myopia(<−6D) | 32 (21.2%) | 38 (25.7%) | 70 (23.4%) | |
|
| 0.326 | |||
| Low myopia (>−3 D) | 52 (33.5%) | 58 (39.7%) | 110 (36.5%) | |
| Moderate myopia (between −6 D and −3D) | 59 (38.1%) | 44 (30.1%) | 103 (34.2%) | |
| High myopia (<−6D) | 44 (28.4%) | 44 (30.1%) | 88 (29.2%) | |
|
| ||||
| Recommendation from relatives and friends | 99 (63.9%) | 95 (63.3%) | 194 (63.6%) | 0.922 |
| Recommendation from doctors | 51 (32.9%) | 58 (38.7%) | 109 (35.7%) | 0.294 |
| Internet | 39 (25.2%) | 32 (21.3%) | 71 (23.3%) | 0.429 |
| Health education instructions | 6 (3.9%) | 7 (4.7%) | 13 (4.3%) | 0.731 |
| Myopia control conference | 5 (3.2%) | 3 (2.0%) | 8 (2.6%) | 0.723 |
Data are presented as n (%) or mean ± standard deviation. * p-value < 0.05 was considered statistically significant after test. Abbreviations: D = Diopter; Ortho-K = Orthokeratology.
Characteristics of wearers in myopia control.
| Variable | Male | Female | Total | |
|---|---|---|---|---|
| N | 155 | 150 | 305 | |
|
| 0.057 | |||
| <1 year | 14 (9.2%) | 8 (5.3%) | 22 (7.3%) | |
| 1–3 years | 55 (35.9%) | 40 (26.7%) | 95 (31.4%) | |
| ≥3 years | 84 (54.9%) | 102 (68.0%) | 186 (61.4%) | |
|
| 0.841 | |||
| No | 42 (30.0%) | 35 (25.7%) | 77 (27.9%) | |
| <1 year | 21 (15.0%) | 19 (14.0%) | 40 (14.5%) | |
| 1–3 years | 34 (24.3%) | 36 (26.5%) | 70 (25.4%) | |
| ≥3 years | 43 (30.7%) | 46 (33.8%) | 89 (32.2%) | |
|
| 0.071 | |||
| No | 110 (94.8%) | 98 (84.5%) | 208 (89.7%) | |
| <1 year | 4 (3.4%) | 10 (8.6%) | 14 (6.0%) | |
| 1–3 years | 1 (0.9%) | 3 (2.6%) | 4 (1.7%) | |
| ≥3 years | 1 (0.9%) | 5 (4.3%) | 6 (2.6%) | |
|
| 0.322 | |||
| No | 27 (18.6%) | 31 (22.6%) | 58 (20.6%) | |
| <1 year | 61 (42.1%) | 43 (31.4%) | 104 (36.9%) | |
| 1–3 years | 37 (25.5%) | 40 (29.2%) | 77 (27.3%) | |
| ≥3 years | 20 (13.8%) | 23 (16.8%) | 43 (15.2%) | |
|
| ||||
| Inconvenient with glasses wearing | 103 (66.5%) | 95 (63.3%) | 198 (64.9%) | 0.568 |
| Discomfort with Atropine use | 20 (12.9%) | 20 (13.3%) | 40 (13.1%) | 0.911 |
| Recommended by others | 36 (23.2%) | 45 (30.0%) | 81 (26.6%) | 0.180 |
| Efficacy in myopia control | 121 (78.1%) | 112 (74.7%) | 233 (76.4%) | 0.485 |
| Only night wearing | 71 (45.8%) | 74 (49.3%) | 145 (47.5%) | 0.537 |
|
| ||||
| Reasonable price | 15 (9.7%) | 18 (12.0%) | 33 (10.8%) | 0.514 |
| Professionalism | 83 (53.5%) | 86 (57.3%) | 169 (55.4%) | 0.506 |
| Recommended by relatives or friends | 86 (55.5%) | 75 (50.0%) | 161 (52.8%) | 0.338 |
| Regular follow-up | 83 (53.5%) | 72 (48.0%) | 155 (50.8%) | 0.333 |
| Searching in internet | 9 (5.8%) | 7 (4.7%) | 16 (5.2%) | 0.655 |
Data are presented as n (%) or mean ± standard deviation.
Insertion related information.
| Variable | <12 y/o | 12–15 y/o | >15 y/o | Total | |
|---|---|---|---|---|---|
| N | 116 | 114 | 75 | 305 | |
|
| <0.001 * | ||||
| Oneself | 41 (35.3%) | 88 (77.2%) | 72 (96.0%) | 201 (65.9%) | |
| by Others | 75 (64.7%) | 26 (22.8%) | 3 (4.0%) | 104 (34.1%) | |
|
| <0.001 * | ||||
| Oneself | 40 (34.5%) | 87 (76.3%) | 71 (94.7%) | 198 (64.9%) | |
| by Others | 76 (65.5%) | 27 (23.7%) | 4 (5.3%) | 107 (35.1%) | |
|
| 0.001 * | ||||
| Regular visits (Every 2–3 months) | 113 (97.4%) | 101 (88.6%) | 57 (77.0%) | 271 (89.1%) | |
| Regular visits (Every 5–6 months) | 1 (0.9%) | 6 (5.3%) | 9 (12.2%) | 16 (5.3%) | |
| Irregular visits | 2 (1.7%) | 7 (6.1%) | 8 (10.8%) | 17 (5.6%) | |
|
| 70 (80.5%) | 88 (85.4%) | 56 (88.9%) | 214 (84.6%) | 0.352 |
|
| 26 (22.4%) | 34 (29.8%) | 24 (32.4%) | 84 (27.6%) | 0.258 |
Data are presented as n (%) or mean ± standard deviation. * p-value < 0.05 was considered statistically significant after test.
Insertion behaviors of orthokeratology wearers.
| Variable | Male | Female | Total | |
|---|---|---|---|---|
| N | 155 | 150 | 305 | |
|
| 94 (60.6%) | 107 (71.3%) | 201 (65.9%) | 0.049 * |
|
| 93 (60.0%) | 105 (70.0%) | 198 (64.9%) | 0.067 |
|
| 141 (91.0%) | 136 (90.7%) | 277 (90.8%) | 0.927 |
|
| 0.052 | |||
| Less than 6 h | 6 (3.8%) | 14 (9.4%) | 20 (6.6%) | |
| More than 6 h | 149 (96.2%) | 135 (90.6%) | 284 (93.4%) | |
|
| 0.159 | |||
| Less than or equal to 5 days | 28 (18.1%) | 18 (12.2%) | 46 (15.2%) | |
| Greater than or equal to 6 days | 127 (81.9%) | 129 (87.8%) | 256 (84.8%) | |
|
| 0.124 | |||
| Povidone iodine-based disinfecting solution | 88 (57.1%) | 72 (48.3%) | 160 (52.8%) | |
| Rub with daily cleaner | 66 (42.9%) | 77 (51.7%) | 143 (47.2%) | |
|
| 0.685 | |||
| Yes (Average once per two weeks) | 62 (51.2%) | 71 (53.8%) | 133 (52.6%) | |
| No | 59 (48.8%) | 61 (46.2%) | 120 (47.4%) | |
|
| 0.423 | |||
| Regular visits (Every2- 3 months) | 136 (87.7%) | 135 (90.6%) | 271 (89.1%) | |
| Irregular visits | 19 (12.3%) | 14 (9.4%) | 33 (10.9%) | |
|
| 116 (87.9%) | 98 (81.0%) | 214 (84.6%) | 0.130 |
|
| 45 (29.0%) | 39 (26.2%) | 84 (27.6%) | 0.578 |
|
| 0.280 | |||
| Clear all day | 133 (85.8%) | 121 (81.2%) | 254 (83.6%) | |
| Blurred after noon | 22 (14.2%) | 28 (18.8%) | 50 (16.4%) |
Data are presented as n (%) or mean ± standard deviation. * p-value < 0.05 was considered statistically significant after test.
Time in near work and outdoor activity (mean hours per day).
| Variable | Total | <12 y/o | 12–15 y/o | >15 y/o | ||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | |||
| N | 305 | 62 | 55 | 62 | 51 | 30 | 45 | |
|
| 0.006 * | |||||||
| Less than 8 h | 159 (52.5%) | 41 (66.1%) | 34 (64.1%) | 25 (40.3%) | 24 (47.1%) | 18 (60.0%) | 17 (37.8%) | |
| More than 8 h | 144 (47.5%) | 21 (33.9%) | 19 (35.8%) | 37 (59.7%) | 27 (52.9%) | 12 (40.0%) | 28 (62.2%) | |
|
| <0.001 * | |||||||
| Less than 8 h | 232 (76.6%) | 55 (88.7%) | 50 (90.9%) | 42 (67.7%) | 40 (78.4%) | 18 (62.91%) | 27 (61.4%) | |
| More than 8 h | 71 (23.4%) | 7 (11.3%) | 5 (9.1%) | 20 (32.3%) | 11 (21.6%) | 11 (37.9%) | 17 (38.6%) | |
|
| <0.001 * | |||||||
| Less than 1 h | 141 (46.4%) | 49 (79.0%) | 42 (76.4%) | 25 (40.3%) | 18 (35.3%) | 4 (13.3%) | 3 (6.8%) | |
| Between 1 to 6 h | 149 (49.0%) | 13 (21.0%) | 12 (21.8%) | 35 (56.5%) | 32 (62.7%) | 20 (66.7%) | 37 (84.1%) | |
| More than 6 h | 14 (4.6%) | 0 (0.0%) | 1 (1.8%) | 2 (3.2%) | 1 (2.0%) | 6 (20.0%) | 4 (9.1%) | |
|
| <0.001 * | |||||||
| Less than 1 h | 62 (20.3%) | 26 (41.9%) | 19 (34.5%) | 8 (12.9%) | 6 (11.8%) | 1 (3.3%) | 2 (4.4%) | |
| Between 1 to 6 h | 204 (66.9%) | 33 (53.2%) | 32 (58.2%) | 45 (72.6%) | 41 (80.4%) | 20 (66.7%) | 33 (73.3%) | |
| More than 6 h | 39 (12.8%) | 3 (4.8%) | 4 (7.3%) | 9 (14.5%) | 4 (7.8%) | 9 (30.0%) | 10 (22.2%) | |
|
| 0.001 * | |||||||
| Less than 1 h | 139 (45.6%) | 19 (30.6%) | 25 (45.5%) | 34 (54.8%) | 30 (58.8%) | 6 (20.0%) | 25 (55.6%) | |
| Between 1 to 6 h | 159 (52.1%) | 42 (67.7%) | 29 (52.7%) | 24 (38.7%) | 20 (39.2%) | 24 (80.0%) | 20 (44.4%) | |
| More than 6 h | 7 (2.3%) | 1 (1.6%) | 1 (1.8%) | 4 (6.5%) | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) | |
|
| <0.001 * | |||||||
| Less than 1 h | 137 (44.9%) | 18 (29.0%) | 24 (43.6%) | 23 (45.8%) | 36 (70.6%) | 5 (16.7%) | 31 (68.9%) | |
| Between 1 to 6 h | 162 (53.1%) | 42 (67.7%) | 31 (56.4%) | 36 (50.0%) | 14 (27.5%) | 25 (83.3%) | 14 (31.1%) | |
| More than 6 h | 6 (2.0%) | 2 (3.2%) | 0 (0.0%) | 3 (4.2%) | 1 (2.0%) | 0 (0.0%) | 0 (0.0%) | |
Data are presented as n (%) or mean ± standard deviation. * p-value < 0.05 was considered statistically significant after test.
Satisfaction with orthokeratology wearing.
| Variable | Male | Female | Total | |
|---|---|---|---|---|
| N | 155 | 150 | 305 | |
|
| 0.034 * | |||
| Acceptable | 20 (12.9%) | 33 (22.1%) | 53 (17.4%) | |
| Satisfied or very satisfied | 135 (87.1%) | 116 (77.9%) | 251 (82.6%) | |
|
| 0.995 | |||
| Acceptable | 53 (34.2%) | 51 (34.2%) | 104 (34.2%) | |
| Easy or very easy | 102 (65.8%) | 98 (65.8%) | 200 (65.8%) | |
|
| 0.392 | |||
| Expensive | 104 (67.5%) | 93 (62.8%) | 197 (65.2%) | |
| Acceptable | 50 (32.5%) | 55 (37.2%) | 105 (34.8%) | |
|
| 0.527 | |||
| Acceptable | 17 (11.0%) | 20 (13.3%) | 37 (12.1%) | |
| Satisfied or very satisfied | 138 (89.0%) | 130 (86.7%) | 268 (87.9%) | |
|
| 146 (97.3%) | 146 (99.3%) | 292 (98.3%) | 0.371 |
Data are presented as n (%) or mean ± standard deviation. * p-value < 0.05 was considered statistically significant after test. Abbreviations: AL = Axial Length.
Factors associated with clear day vision and side effects.
| Item | Clear Day Vision | Lens Binding | Punctate Keratitis | Decentration | ||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
|
| ||||||||
| <12 years old | Ref. | Ref. | Ref. | Ref. | ||||
| 12–15 years old | 0.93 (0.32, 2.72) | 0.891 | 1.26 (0.59, 2.67) | 0.549 | 0.94 (0.27, 3.27) | 0.926 | 0.84 (0.32, 2.22) | 0.724 |
| >15 years old | 0.70 (0.18, 2.66) | 0.598 | 0.92 (0.33, 2.56) | 0.878 | 0.71 (0.13, 3.92) | 0.697 | 0.78 (0.20, 3.00) | 0.717 |
|
| ||||||||
| Male | Ref. | Ref. | Ref. | Ref. | ||||
| Female | 0.75 (0.32, 1.72) | 0.493 | 1.62 (0.89, 2.98) | 0.117 | 1.63 (0.58, 4.61) | 0.353 | 1.09 (0.49, 2.42) | 0.825 |
|
| 1.75 (1.35, 2.25) |
| 0.93 (0.77, 1.11) | 0.408 | 0.85 (0.63, 1.15) | 0.298 | 0.97 (0.77, 1.24) | 0.824 |
|
| ||||||||
| Normal | Ref. | Ref. | Ref. | Ref. | ||||
| Flatter | 0.76 (0.16, 3.57) | 0.723 | 2.53 (0.7, 9.19) | 0.157 | 3.6 (0.59, 22.03) | 0.165 | 0.74 (0.12, 4.53) | 0.744 |
| Steeper | 3.49 (0.68, 17.98) | 0.135 | 1.26 (0.53, 2.99) | 0.605 | 1.79 (0.49, 6.50) | 0.376 | 1.47 (0.52, 4.21) | 0.470 |
|
| 0.59 (0.34, 1.01) | 0.056 | 1 (0.66, 1.51) | 0.999 | 1.5 (0.66, 3.38) | 0.330 | 0.77 (0.47, 1.26) | 0.295 |
|
| ||||||||
| Self | Ref. | Ref. | Ref. | Ref. | ||||
| Others | 0.89 (0.32, 2.45) | 0.817 | 1.38 (0.68, 2.8) | 0.372 | 1.01 (0.32, 3.21) | 0.981 | 0.64 (0.25, 1.61) | 0.340 |
|
| ||||||||
| <6 h | Ref. | Ref. | Ref. | Ref. | ||||
| 6–8 h | 1.67 (0.41, 6.85) | 0.477 | 1.12 (0.35, 3.66) | 0.846 | 1.81 (0.2, 16.51) | 0.597 | 1.13 (0.22, 5.85) | 0.881 |
| >8 h | 0.49 (0.10, 2.33) | 0.370 | 0.76 (0.21, 2.77) | 0.678 | 1.05 (0.1, 11.51) | 0.968 | 1.89 (0.33, 10.95) | 0.476 |
|
| ||||||||
| ≦5 days | Ref. | Ref. | Ref. | Ref. | ||||
| ≧6 days | 1.34 (0.47, 3.88) | 0.584 | 0.46 (0.21, 0.99) |
| 0.57 (0.16, 2.05) | 0.393 | 2.04 (0.56, 7.39) | 0.280 |
|
| ||||||||
| No | Ref. | Ref. | Ref. | Ref. | ||||
| Yes | 2.65 (1.08, 6.53) |
| 1.09 (0.59, 2.01) | 0.780 | 0.66 (0.24, 1.84) | 0.428 | 2.13 (0.92, 4.93) | 0.079 |
|
| ||||||||
| Povidone iodine-based disinfecting solution | Ref. | Ref. | Ref. | Ref. | ||||
| Rub with daily cleaner | 1.21 (0.45, 3.26) | 0.700 | 1.00 (0.51, 1.97) | 0.991 | 1.64 (0.52, 5.15) | 0.395 | 0.79 (0.32, 1.94) | 0.608 |
|
| ||||||||
| Non-regular visits | Ref. | Ref. | Ref. | Ref. | ||||
| Regular visits (Every 2–3 months) | 2.42 (0.81, 7.25) | 0.113 | 0.95 (0.37, 2.43) | 0.913 | 3.33 (0.38, 29.39) | 0.279 | 2.23 (0.47, 10.56) | 0.313 |
|
| 0.97 (0.92, 1.03) | 0.330 | 0.98 (0.94, 1.02) | 0.238 | 0.97 (0.91, 1.04) | 0.410 | 1.02 (0.97, 1.08) | 0.341 |
|
| ||||||||
| No | Ref. | Ref. | Ref. | Ref. | ||||
| Yes | 0.49 (0.17, 1.4) | 0.181 | 1.49 (0.67, 3.32) | 0.327 | 0.92 (0.22, 3.81) | 0.912 | 0.78 (0.28, 2.24) | 0.651 |
Data are presented as Odds ratio (95% CI), * p-value < 0.05 was considered statistically significant after test. Abbreviations: Ref. = Reference.
Figure 1Prevalence (a) and severity (b) of discomfort symptoms.
Figure 2The reasons (a) and concerns (b) of Ortho-K use from the parents/guardian.